Investment
Participated in Leal Therapeutics' $30M Series A financing for neuro-metabolic CNS therapeutics.
Leal Therapeutics
Leal TherapeuticsNewpath Partners
AUG 27, 2025
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Leal Therapeutics